losartan has been researched along with Facies in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Facies: The appearance of the face that is often characteristic of a disease or pathological condition, as the elfin facies of WILLIAMS SYNDROME or the mongoloid facies of DOWN SYNDROME. (Random House Unabridged Dictionary, 2d ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappuccio, G | 1 |
| Caiazza, M | 1 |
| Roca, A | 1 |
| Melis, D | 2 |
| Iuliano, A | 1 |
| Matyas, G | 1 |
| Rubino, M | 1 |
| Limongelli, G | 1 |
| Brunetti-Pierri, N | 2 |
| Piccolo, P | 1 |
| Mithbaokar, P | 1 |
| Sabatino, V | 1 |
| Tolmie, J | 1 |
| Schiaffino, MC | 1 |
| Filocamo, M | 1 |
| Andria, G | 1 |
1 trial available for losartan and Facies
| Article | Year |
|---|---|
A pilot clinical trial with losartan in Myhre syndrome.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Child; Child, Preschool; Cryptorchidism; | 2021 |
1 other study available for losartan and Facies
| Article | Year |
|---|---|
SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan.
Topics: Adolescent; Adult; Child; Cryptorchidism; Extracellular Matrix; Facies; Female; Fibroblasts; Growth | 2014 |